Clinical trial results of the HER‐2/<i>neu</i> (E75) vaccine to prevent breast cancer recurrence in high‐risk patients - Concepedia

Concepedia

Publication | Open Access

Clinical trial results of the HER‐2/<i>neu</i> (E75) vaccine to prevent breast cancer recurrence in high‐risk patients

DOI Full Paper Access

170

Citations

15

References

2011

Year

Elizabeth A. Mittendorf, Guy T. Clifton, Jarrod P. Holmes, Kevin S. Clive, Ritesh Patil, Linda C. Benavides, Jeremy D. Gates, Alan K. Sears, Alexander Stojadinovic, Sathibalan Ponniah,

Abstract

The E75 vaccine has clinical efficacy that is more prominent in certain patients. A phase 3 trial enrolling lymph node-positive patients with HER2 low-expressing tumors is warranted.

References

	Year	Citations

Page 1